Back to Search
Start Over
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy.
- Source :
-
Frontiers in psychiatry [Front Psychiatry] 2023 Oct 19; Vol. 14, pp. 1272959. Date of Electronic Publication: 2023 Oct 19 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Introduction: Vaccination against SARS-CoV-2 has been used to reduce the severity of COVID-19 disease and the incidence of new cases. However, a significant proportion of people have shown vaccination hesitancy.<br />Methods: This study explored psychological factors related to vaccination hesitancy in a sample of Italian COVID-19 patients ( N = 54), hospitalized during 2021, after vaccines had been made available and while the vaccination campaign was on-going. Consecutive patients, aged 18 or older, admitted to the hospital with a diagnosis of COVID-19 were assessed with a set of standardized measures.<br />Results: In our sample, 48.1% was not vaccinated and 7.4% died within 6months after hospitalization, with a preponderance of deaths among non-vaccinated patients. Non-vaccinated participants had higher resilience scores at the CD-RISC-10 scale than vaccinated ones (33.6 ± 5.50 vs 28.6 ± 6.61; t40.2=+ 2.94, p = 0.005). No statistically significant differences were found between the two groups for any other measures.<br />Discussion: Higher levels of resilience among non-vaccinated patients may reflect greater identity worth and self-esteem, in turn resulting in a decrease in vaccination likelihood. This finding may have important public health implications, as it indicates that specific psychological aspects, such as resilience, may result in vaccination hesitancy, with implications for hospitalization rates, and thus healthcare costs, as well as loss of lives.<br />Competing Interests: CT has received grants in the last 2 years from Correvio, Biotest, Biomerieux, Gilead, Angelini, Pfizer, Thermofisher, Zambon, Shionogi, Avir Pharma, and Hikma, outside of this work. MCo has been a consultant/advisor to GW Pharma Limited, GW Pharma Italy SRL, and F. Hoffmann-La Roche Limited, outside of this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Comacchio, Cesco, Martinelli, Garzitto, Bianchi, Innocente, Sozio, Tascini, Balestrieri and Colizzi.)
Details
- Language :
- English
- ISSN :
- 1664-0640
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 37928916
- Full Text :
- https://doi.org/10.3389/fpsyt.2023.1272959